COLLEGIUM PHARMACEUTICAL, INC (COLL) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US19459J1043
COLLEGIUM PHARMACEUTICAL, INC financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 780.57 m USD |
| Gross profit | 463.26 m USD |
| Operating income | 179.64 m USD |
| EBIT | 174.93 m USD |
| Net income | 62.87 m USD |
| Diluted EPS – continuing operations | 1.73 USD |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About COLLEGIUM PHARMACEUTICAL, INC
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for the management of pain severe enough to require daily; Nucynta ER and Nucynta IR, which are extended-release and immediate-release oral formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. Collegium Pharmaceutical, Inc. was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. The company was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
More stocks
- Knight Therapeutics Inc (GUD.TO)
- Evolv Technologies Holdings, Inc. (EVLV)
- Chongqing Pharscin Pharmaceutical Co Ltd (002907.SZ)
- JW Pharmaceutical Corp (001067.KS)
- Yonyou Auto Information Technology (Shanghai) Co. Ltd. (688479.SS)
- Hangzhou Star Shuaier Electric Appliance Co Ltd (002860.SZ)
- Nextdoor Holdings, Inc. (NXDR)
- KRONOS WORLDWIDE INC (KRO)
- Corvus Pharmaceuticals, Inc. (CRVS)
- Riley Exploration Permian, Inc. (REPX)
- Sinostone Guangdong Co Ltd (001212.SZ)
- Jinxin Fertility Group Ltd (1951.HK)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.